VANCOUVER, British Columbia, Aug.23, 2017(GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) ("Cypress" or the "Company") announces that it has cancelled the Glory Property Option Agreement, dated August 22, 2016, with Pure Energy Minerals for failure, by Pur...Read More
VANCOUVER, British Columbia, Aug.10, 2017(GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) ("Cypress" or the "Company") is pleased to announce it has initiated an application to the Bureau of Land Management (BLM), Nevada, for an area of disturbance permit...Read More
VANCOUVER, British Columbia, July11, 2017(GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) ("Cypress" or the "Company") is pleased to announce that it held its annual general meeting on July 10, 2017.The Company reports that Donald Huston, James Pettit, Don...Read More
Cynata Pre-IND meeting with the US FDA completed successfullyFDA confirms Cymerus?,,? manufacturing dossier meets expectationsClear path determined for preclinical and clinical protocol requirements for product development in USPotential to take advantage of fast-track provisions under the new 21...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 31, 2017) - Cypress Development Corp. (TSX VENTURE:CYP)(OTCBB:CYDVF)(FRANKFURT:C1Z1) ("Cypress" or the "Company") is pleased to announce that Mr. Don Mosher has been appointed to the position of Corporate Development for the Company. Mr. Moshe...Read More
VANCOUVER, B.C., June06, 2017(GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) ("Cypress" or the "Company") is pleased to announce, further to its News Release on May 15th, that the Company has received additional assay results from a 2017 Phase 1 core drill...Read More
VANCOUVER, B.C., June20, 2017(GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) ("Cypress" or the "Company") is pleased to announce, further to its News Releases on June 6th and May 15th, that the Company has received final assay results from a 2017 Phase 1...Read More
Application filed with IP Australia would expand patent estate to immunotherapyCreates new opportunities in the growing field of immunotherapy and reinforces a position in oncologyMELBOURNE, Australia, June20, 2017(GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata...Read More
VANCOUVER, B.C., June21, 2017(GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCBB:CYDVF) (Frankfurt:C1Z1) ("Cypress" or the "Company") is pleased to announce that Dr. Bill Willoughby, PE, has agreed to join Cypress' Technical Advisory Board. Dr. Willoughby will assist Company managem...Read More